0001209191-23-004567.txt : 20230124
0001209191-23-004567.hdr.sgml : 20230124
20230124160055
ACCESSION NUMBER: 0001209191-23-004567
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230120
FILED AS OF DATE: 20230124
DATE AS OF CHANGE: 20230124
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Tray Thomas
CENTRAL INDEX KEY: 0001912317
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-12400
FILM NUMBER: 23548134
MAIL ADDRESS:
STREET 1: C/O INCYTE CORPORATION
STREET 2: 1801 AUGUSTINE CUT-OFF
CITY: WILMINGTON
STATE: DE
ZIP: 19803
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: INCYTE CORP
CENTRAL INDEX KEY: 0000879169
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
IRS NUMBER: 943136539
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1801 AUGUSTINE CUT-OFF
CITY: WILMINGTON
STATE: DE
ZIP: 19803
BUSINESS PHONE: 3024986700
MAIL ADDRESS:
STREET 1: 1801 AUGUSTINE CUT-OFF
CITY: WILMINGTON
STATE: DE
ZIP: 19803
FORMER COMPANY:
FORMER CONFORMED NAME: INCYTE CORP
DATE OF NAME CHANGE: 20030318
FORMER COMPANY:
FORMER CONFORMED NAME: INCYTE GENOMICS INC
DATE OF NAME CHANGE: 20000710
FORMER COMPANY:
FORMER CONFORMED NAME: INCYTE PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19930902
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2023-01-20
0
0000879169
INCYTE CORP
INCY
0001912317
Tray Thomas
1801 AUGUSTINE CUT-OFF
WILMINGTON
DE
19803
0
1
0
0
Principal Accounting Officer
Common Stock
2023-01-20
4
A
0
2833
0.00
A
19439
D
Employee Stock Option (right to buy)
83.20
2023-01-20
4
A
0
2968
0.00
A
2033-01-19
Common Stock
2968
2968
D
Represents award of restricted stock units ("RSUs") that will vest 100% on the fourth anniversary of the award, subject to Thomas Tray's continued service with the issuer through the applicable vesting date. The RSUs may be settled only for shares of common stock on a one-for-one basis.
Includes an aggregate of 15,080 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested. The aggregate amount also includes the additional restricted stock granted on January 20, 2023.
Beginning January 20, 2023, options become exercisable in 37 installments, with the first 25% vesting on July 2, 2023 after one year and the remainder vesting monthly over three years.
/s/ Elizabeth Feeney, Attorney-In-Fact
2023-01-24